Maria A Perry
mariaaperry.bsky.social
Maria A Perry
@mariaaperry.bsky.social
Reposted by Maria A Perry
A new study led by MSK computational biologist Kanika Arora and MSK molecular geneticist Dr. Debyani Chakravarty, uncovers why new precision oncology treatments benefit patients of some ancestries more than others. Learn more:
Why New Precision Oncology Cancer Treatments Benefit Patients of Some Ancestries More Than Others
Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ancestries, according to new MSK research. This trend could exacerbate disparit...
www.mskcc.org
January 16, 2025 at 4:52 PM